| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |